n-pentanoic acid has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, R; Li, Y; Ling, C; Lu, L; Yang, H | 1 |
1 other study(ies) available for n-pentanoic acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer.
Topics: Animals; Caspase 3; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Male; Mice; Pentanoic Acids; Prostate; Prostatic Neoplasms | 2022 |